The aims of this study are: (1) to discover and begin to validate molecular and neuroimaging biomarkers of traumatic brain injury (TBI), and (2) to develop regional biobanks linked to a national database for patients with TBI.


Results from this study will lead to improved prognostic models to deliver tailored management strategies and to allow early risk stratification in future clinical trials. The ultimate goal is to improve the quality of care and quality of life outcomes for patients with TBI and their families.

For questions relating to CanTBI, please email